Boston Scientific Acquires Bayer Interventional
We are pleased to inform you that on August 29, 2014 Boston Scientific closed its acquisition of the Interventional Division of Bayer.
Bayer’s strong commercial team and innovative products are a natural complement to Boston Scientific’s market-leading Peripheral Interventions business. This acquisition will strengthen our ability to provide you with a complete portfolio of solutions for challenging conditions while enhancing the clinical support we offer you.
Should you have any questions, please contact either your Bayer Interventional or Boston Scientific Peripheral or Coronary Sales Representative.
Bayer: (855) 217.2143 or fax (412) 767.4120
Boston Scientific: (888) 272.1001 or fax (888) 272.9444
For DVT interventional therapy information, visit www.DVTfast.com